Cancer immunology and immunotherapy

Open Access
Advances in strategies to improve the immunotherapeutic efficacy of chimeric antigen receptor-T cell therapy for lymphoma
Tianshu Yu, Xianhuo Wang, Ou Bai, Huilai Zhang and Wenbin Qian

Cancer Biology & Medicine April 2025, 22 (4) 301-321; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0538
Open Access
Application and future prospects of bispecific antibodies in the treatment of non-small cell lung cancer
Junxu Wen, Wenxing Cui, Xiaoyan Yin, Yu Chen, Ailing Liu, Qian Wang and Xiangjiao Meng

Cancer Biology & Medicine April 2025, 22 (4) 348-375; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0470
Open Access
Neoepitope BTLA^P267L-specific TCR-T cell immunotherapy unlocks precision treatment for hepatocellular carcinoma
Fang Liu, Hua Chen, Suxin Wu, Chenlu Zhu, Mingji Zhang, Wei Rui, Dong Zhou, Yang Wang, Xin Lin, Xueqiang Zhao and Yunbin Ye

Cancer Biology & Medicine April 2025, 22 (4) 412-432; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0434
Open Access
Optimal immunotherapy duration in advanced NSCLC: defining the ideal treatment window
Kaibo Ding, Dujiang Liu, Xinyue Li, Zhongsheng Peng, Lin Zhu and Yanjun Xu

Cancer Biology & Medicine March 2025, 22 (3) 284-294; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0457
Open Access
Current status of multiple markers in precision immunotherapy for colorectal cancer
Chao Liu, Ya Lan, Hong Wang and Yanqiao Zhang

Cancer Biology & Medicine March 2025, 22 (3) 205-211; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0030
Open Access
A novel BaEVRless-LV packaging system for the production of lentiviral vectors for clinical-grade CAR-NK cell manufacturing
Yinyin Zhang, Minghuan Zhang, Mengyuan Li, Lihong Zong, Qian Ye, Wen Lei, Wenhai Deng and Wenbin Qian

Cancer Biology & Medicine February 2025, 22 (2) 137-143; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0551
Open Access
Antibody-drug conjugates in breast cancer: advances and prospects
Zhiqiang Shi, Yongjin Lu, Qiuchen Zhao, Yongsheng Wang and Pengfei Qiu

Cancer Biology & Medicine February 2025, 22 (2) 83-92; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0486
Open Access
Elucidating the synergistic roles of CD4⁺ T and dendritic cells in antitumor immunity
Xiubao Ren

Cancer Biology & Medicine January 2025, 22 (1) 1-5; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0453
Open Access
Advancing precision medicine: the transformative role of artificial intelligence in immunogenomics, radiomics, and pathomics for biomarker discovery and immunotherapy optimization
Luchen Chang, Jiamei Liu, Jialin Zhu, Shuyue Guo, Yao Wang, Zhiwei Zhou and Xi Wei

Cancer Biology & Medicine January 2025, 22 (1) 33-47; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0376
Open Access
Osimertinib exacerbates immune checkpoint inhibitor-related severe adverse events by activating the IL-6/JAK/STAT3 pathway in macrophages
Yuan Li, Yanping Chen, Yuan Meng, Meng Shen, Fan Yang and Xiubao Ren

Cancer Biology & Medicine December 2024, 21 (12) 1156-1170; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0269

Main menu

User menu

Search

Cancer immunology and immunotherapy

Pages

Navigate

More Information

For Authors

Journal Services